Month: January 2025

This in-depth feature by Drug Discovery & Development traces Innophore’s journey from a 30-person Austrian startup to a strategic NVIDIA partner showcased at both the J.P. Morgan Healthcare Conference and

Austrian technology outlet futurezone reports on the expanding partnership between NVIDIA and the Graz-based biotech company Innophore, highlighted by NVIDIA CEO Jensen Huang at CES in Las Vegas. The collaboration

Pharmaceutical Technology reports on NVIDIA’s endorsement of the Innophore partnership for modelling drug dynamics with AI. Innophore’s CavitOmiX platform uses deep learning to screen for new drug candidates, predict hidden

In this official NVIDIA Success Story, Innophore demonstrates how GPU-accelerated computing, the BioNeMo framework, and Amazon Web Services are revolutionizing drug discovery workflows. By leveraging NVIDIA GPUs and RAPIDS, Innophore

What began as a practical exercise in a structural bioinformatics course at the University of Graz led to a Nature Correspondence: we identified systematic stereochemical errors in AlphaFold 3, the

Yahoo Finance, via GlobalData, reports on NVIDIA championing the Innophore partnership to model drug dynamics with artificial intelligence. The CavitOmiX AI platform is designed to predict hidden side effects and

Austrian startup media Trending Topics reports on the collaboration between Innophore and NVIDIA, announced during Jensen Huang’s CES keynote address in January 2025. The Graz-based company, founded in 2017, uses